These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 394434)

  • 21. Specificity of immune complex/complement deposits in the mediation of immunologic injury to renal allografts.
    Shabtai M; Waltzer WC; Miller F; Anaise D; Rapaport FT
    Transplant Proc; 1989 Feb; 21(1 Pt 1):278-9. PubMed ID: 2650119
    [No Abstract]   [Full Text] [Related]  

  • 22. Presence of IgG HLA antibodies in patients with long-surviving renal allografts.
    Norman PJ; Harmer AW; Koffman CG; Vaughan RW
    Transplant Proc; 1995 Feb; 27(1):999-1000. PubMed ID: 7879260
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of antibodies on human renal allografts.
    Porter KA
    Transplant Proc; 1976 Jun; 8(2):189-97. PubMed ID: 779179
    [No Abstract]   [Full Text] [Related]  

  • 24. The absence of early rejection crises in human renal allografts as predicted by capillary agglutinating antibodies.
    Stiller CR; Olson R; Haystead J; Dossetor JB
    Transplantation; 1972 Oct; 14(4):521-3. PubMed ID: 4566168
    [No Abstract]   [Full Text] [Related]  

  • 25. Antibody and lymphocyte-mediated immunologic recipient versus donor reactions before and after human renal allotransplantation--a prospective study.
    Grunnet N; Kristensen T
    Transplant Proc; 1978 Sep; 10(3):531-3. PubMed ID: 362630
    [No Abstract]   [Full Text] [Related]  

  • 26. Composition, subclass distribution, and preliminary analysis of the functions of host inflammatory cells infiltrating renal allografts during rejection.
    Häyry P; Soots A; von Willebrand E; Wiktorowicz K
    Transplant Proc; 1979 Mar; 11(1):785-9. PubMed ID: 377712
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunoglobulin G subclasses and susceptibility to allosensitization in humans.
    Okasha K; Saxena A; el Bedowey MM; Shoker AS
    Clin Nephrol; 1997 Sep; 48(3):165-72. PubMed ID: 9342488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The role of humoral antibodies in the rejection of a kidney allograft (a review of the literature)].
    Drannik GN; Driianskaia VE
    Vrach Delo; 1990 May; (5):45-9. PubMed ID: 2204199
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of antibody in rat renal allograft rejection. II. Failure to enhance renal allografts by sensitization to donor class I antigens presented by donor strain erythrocytes.
    Majoor GD; Van Breda Vriesman PJ
    Transplantation; 1983 Feb; 35(2):121-6. PubMed ID: 6338632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro B cell response in long-term renal transplant recipients.
    Weimer R; Zipperle S; Daniel V; Pomer S; Staehler G; Opelz G
    Transplant Proc; 1992 Dec; 24(6):2537-8. PubMed ID: 1465858
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 33. The significance of the IgG anti-B-cell crossmatch on renal transplant outcome.
    Ghasemian SR; Light JA; Currier CB; Sasaki T; Aquino A; Rees J; Ward W; Carr J
    Clin Transplant; 1997 Oct; 11(5 Pt 2):485-7. PubMed ID: 9361946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperacute rejection from antibody against class II HLA antigens.
    Ghasemian SR; Light JA; Sasaki TA; Barhyte DY
    Clin Transplant; 1998 Dec; 12(6):569-71. PubMed ID: 9850452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of canine renal allografts. II. Studies with Fab fragments.
    Martin DC; Blackwelder R; Rasband R; Morton ME
    Trans Am Assoc Genitourin Surg; 1976; 68():99-101. PubMed ID: 801216
    [No Abstract]   [Full Text] [Related]  

  • 36. Human kidney specific non-MHC antigen: isolation and characterization using eluates from rejected renal allografts.
    Joyce S; Flye MW; Mohanakumar T
    Transplant Proc; 1989 Feb; 21(1 Pt 1):628-9. PubMed ID: 2650207
    [No Abstract]   [Full Text] [Related]  

  • 37. Reactions of kidney cells with cytotoxic antisera: possible evidence of kidney-specific antigens.
    Perkins HA; Gantan Z; Siegel S; Howell E; Belzer FO; Kountz SL
    Tissue Antigens; 1975 Apr; 5(2):89-98. PubMed ID: 1093285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytotoxicity and IL 2 reactivity of cells from rejected or nonrejected allografts.
    Dallman MJ; Wood KJ; Morris PJ
    Transplant Proc; 1988 Apr; 20(2):226-8. PubMed ID: 3129832
    [No Abstract]   [Full Text] [Related]  

  • 39. Four patterns of human renal allograft rejection: a cytologic and in vitro analysis of the infiltrate in 24 irreversibly rejected kidneys.
    Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB
    Transplant Proc; 1977 Mar; 9(1):37-42. PubMed ID: 325780
    [No Abstract]   [Full Text] [Related]  

  • 40. Isolation of human minor histocompatibility peptides from cultured kidney cells.
    Beck Y; Sekimata M; Nakayama S; Müller GA; Müller CA; Yamamoto J; Nagao T; Uchida H; Akiyama N; Kariyone A
    Transplant Proc; 1993 Feb; 25(1 Pt 1):162-6. PubMed ID: 8382382
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.